Great video at bottom of page on Afrezza from VDEX. Scripts hit 390 and Paul Sparks the actor promoting Afrezza. Add in Senate hearings discussing Afrezza and we have a nice groundswell.
Remember SNY reps could walk into any ENDO and get an appointment with a guarantee they would try Afrezza because SNY owned theses doctors. Tritiation wasn't well known and insurance coverage was abysmal that's why refills were poor. Now we have taken care of those issues and our sales force has had some time to gain traction. Summer months are always slow as doctors are off, so getting appointments for patients and sales reps not easy. I've always said we need a good 6-9 months to get things going and scripts would pick up in the fall. Now we have a nice 23% pop in one week and getting more coverage around the country.
Believe me Mike already has several deals set up and just needed to prove out the platform which this weeks scripts are very telling. UAE has shipped IMO and they just can't recognize the revenue until things get started with the actual distribution of the product.
A lot more to come and Paul Sparks found out about Afrezza from the President of JDRF (what's that telling you)? Money not an issue as Mann Foundation and other companies will jump in as sales increase proving the product works. Have two friends this month with Endo appointments who are going to insist on Afrezza. Endo's now seeing the results and will really start to prescribe.
All good and more to come. Catch up with everyone over the weekend. Ask at $1.49 this morning probably explains why no pre-market action. Going to be a good jump in price today.
Market Data 
Markets 
AI
